Royalty Pharma Plc Cl A (RPRX): Congress and insider trades
Who in Congress and inside the company traded RPRX, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Royalty Pharma Plc Cl A (RPRX) is a listed stock on NASDAQ.
- 2 members of Congress filed 2 buys and 0 sells of RPRX, the latest published 2023-06-14 (14 June 2023).
- Insiders filed 0 open market buys worth $0 and 13 sells worth $38M, the latest filed 2026-09-24 (24 September 2026).
- Across 2 scored buys, Congress averaged -20.2% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to draw a conclusion.
- Data as of 2026-09-29 (29 September 2026).
Congress trades in RPRX
as of 2023-06-14| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 14 Jun 2023 | Ro Khanna (D-CA) | buy | 1Kâ15K | 39 | -11.3% |
| 16 Jan 2021 | Phil Roe (R-TN) | buy | 1Kâ15K | 25 | -29.2% |
Nothing matches that search.
Insider trades in RPRX
as of 2026-09-24| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 24 Sep 2026 | Hite Christopher | sell | 100,000 | $58.53 | $5.9M | n/a |
| 19 Aug 2026 | Hite Christopher | sell | 100,000 | $59.97 | $6.0M | n/a |
| 17 Aug 2026 | Coyne Terrance P. | sell | 11,002 | $58.68 | $646K | n/a |
| 2 Jul 2026 | Hite Christopher | sell | 100,000 | $56.52 | $5.7M | n/a |
| 2 Jul 2026 | Urist Marshall | sell | 9,099 | $55.88 | $508K | n/a |
| 2 Jul 2026 | Hite Christopher | sell | 30,000 | $56.46 | $1.7M | n/a |
| 25 Jun 2026 | Urist Marshall | sell | 9,098 | $55.18 | $502K | n/a |
| 25 Jun 2026 | Hite Christopher | sell | 150,000 | $54.40 | $8.2M | n/a |
| 28 May 2026 | Coyne Terrance P. | sell | 64,399 | $53.98 | $3.5M | n/a |
| 21 May 2026 | Urist Marshall | sell | 13,684 | $52.75 | $722K | n/a |
| 30 Apr 2026 | Coyne Terrance P. | sell | 34,791 | $49.78 | $1.7M | n/a |
| 2 Apr 2026 | Coyne Terrance P. | sell | 34,791 | $48.33 | $1.7M | n/a |
| 25 Mar 2026 | Coyne Terrance P. | sell | 34,791 | $45.53 | $1.6M | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought RPRX?
2 Congress buys by 2 members and 0 insider buys are on file. The tables on this page list every one.
Did buying RPRX after a disclosure beat the market?
Across 2 scored buys, Congress averaged -20.2% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.